The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Swine Fever Vaccine Market Research Report 2025
Synopsis
Swine fever, also known as hog cholera, is a contagious viral disease of pigs, including wild boar. The causative virus is a member of the genus Pestivirus of the family Flaviviridae, and is closely related to the viruses of bovine viral diarrhoea and border disease. There is only one serotype of CSF virus (CSFV).
The global Swine Fever Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Swine Fever Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Swine Fever Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Swine Fever Vaccine include WINSUN, CAHIC, Merial, MSD Animal Health, Chopper Biology, Ceva, ChengDu Tecbond, Veterinary and Ringpu Biology, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Swine Fever Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Swine Fever Vaccine.
Report Scope
The Swine Fever Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Swine Fever Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Swine Fever Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
WINSUN
CAHIC
Merial
MSD Animal Health
Chopper Biology
Ceva
ChengDu Tecbond
Veterinary
Ringpu Biology
Qilu Animal
DHN
CAVAC
Komipharm
Agrovet
Bioveta
Jinyu Bio-Technology
Institutul Pasteur
MVP
Tecon
Segment by Type
Tissue Culture Origin
Cell Line Origin
Segment by Application
Government Tender
Market Sales
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Swine Fever Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Swine Fever Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Swine fever, also known as hog cholera, is a contagious viral disease of pigs, including wild boar. The causative virus is a member of the genus Pestivirus of the family Flaviviridae, and is closely related to the viruses of bovine viral diarrhoea and border disease. There is only one serotype of CSF virus (CSFV).
The global Swine Fever Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Swine Fever Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Swine Fever Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Swine Fever Vaccine include WINSUN, CAHIC, Merial, MSD Animal Health, Chopper Biology, Ceva, ChengDu Tecbond, Veterinary and Ringpu Biology, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Swine Fever Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Swine Fever Vaccine.
Report Scope
The Swine Fever Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Swine Fever Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Swine Fever Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
WINSUN
CAHIC
Merial
MSD Animal Health
Chopper Biology
Ceva
ChengDu Tecbond
Veterinary
Ringpu Biology
Qilu Animal
DHN
CAVAC
Komipharm
Agrovet
Bioveta
Jinyu Bio-Technology
Institutul Pasteur
MVP
Tecon
Segment by Type
Tissue Culture Origin
Cell Line Origin
Segment by Application
Government Tender
Market Sales
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Swine Fever Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Swine Fever Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Swine Fever Vaccine Market Overview
1.1 Product Overview and Scope of Swine Fever Vaccine
1.2 Swine Fever Vaccine Segment by Type
1.2.1 Global Swine Fever Vaccine Market Value Comparison by Type (2024-2030)
1.2.2 Tissue Culture Origin
1.2.3 Cell Line Origin
1.3 Swine Fever Vaccine Segment by Application
1.3.1 Global Swine Fever Vaccine Market Value by Application: (2024-2030)
1.3.2 Government Tender
1.3.3 Market Sales
1.4 Global Swine Fever Vaccine Market Size Estimates and Forecasts
1.4.1 Global Swine Fever Vaccine Revenue 2019-2030
1.4.2 Global Swine Fever Vaccine Sales 2019-2030
1.4.3 Global Swine Fever Vaccine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Swine Fever Vaccine Market Competition by Manufacturers
2.1 Global Swine Fever Vaccine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Swine Fever Vaccine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Swine Fever Vaccine Average Price by Manufacturers (2019-2024)
2.4 Global Swine Fever Vaccine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Swine Fever Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Swine Fever Vaccine, Product Type & Application
2.7 Swine Fever Vaccine Market Competitive Situation and Trends
2.7.1 Swine Fever Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Swine Fever Vaccine Players Market Share by Revenue
2.7.3 Global Swine Fever Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Swine Fever Vaccine Retrospective Market Scenario by Region
3.1 Global Swine Fever Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Swine Fever Vaccine Global Swine Fever Vaccine Sales by Region: 2019-2030
3.2.1 Global Swine Fever Vaccine Sales by Region: 2019-2024
3.2.2 Global Swine Fever Vaccine Sales by Region: 2025-2030
3.3 Global Swine Fever Vaccine Global Swine Fever Vaccine Revenue by Region: 2019-2030
3.3.1 Global Swine Fever Vaccine Revenue by Region: 2019-2024
3.3.2 Global Swine Fever Vaccine Revenue by Region: 2025-2030
3.4 North America Swine Fever Vaccine Market Facts & Figures by Country
3.4.1 North America Swine Fever Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Swine Fever Vaccine Sales by Country (2019-2030)
3.4.3 North America Swine Fever Vaccine Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Swine Fever Vaccine Market Facts & Figures by Country
3.5.1 Europe Swine Fever Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Swine Fever Vaccine Sales by Country (2019-2030)
3.5.3 Europe Swine Fever Vaccine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Swine Fever Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Swine Fever Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Swine Fever Vaccine Sales by Country (2019-2030)
3.6.3 Asia Pacific Swine Fever Vaccine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Swine Fever Vaccine Market Facts & Figures by Country
3.7.1 Latin America Swine Fever Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Swine Fever Vaccine Sales by Country (2019-2030)
3.7.3 Latin America Swine Fever Vaccine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Swine Fever Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Swine Fever Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Swine Fever Vaccine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Swine Fever Vaccine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Swine Fever Vaccine Sales by Type (2019-2030)
4.1.1 Global Swine Fever Vaccine Sales by Type (2019-2024)
4.1.2 Global Swine Fever Vaccine Sales by Type (2025-2030)
4.1.3 Global Swine Fever Vaccine Sales Market Share by Type (2019-2030)
4.2 Global Swine Fever Vaccine Revenue by Type (2019-2030)
4.2.1 Global Swine Fever Vaccine Revenue by Type (2019-2024)
4.2.2 Global Swine Fever Vaccine Revenue by Type (2025-2030)
4.2.3 Global Swine Fever Vaccine Revenue Market Share by Type (2019-2030)
4.3 Global Swine Fever Vaccine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Swine Fever Vaccine Sales by Application (2019-2030)
5.1.1 Global Swine Fever Vaccine Sales by Application (2019-2024)
5.1.2 Global Swine Fever Vaccine Sales by Application (2025-2030)
5.1.3 Global Swine Fever Vaccine Sales Market Share by Application (2019-2030)
5.2 Global Swine Fever Vaccine Revenue by Application (2019-2030)
5.2.1 Global Swine Fever Vaccine Revenue by Application (2019-2024)
5.2.2 Global Swine Fever Vaccine Revenue by Application (2025-2030)
5.2.3 Global Swine Fever Vaccine Revenue Market Share by Application (2019-2030)
5.3 Global Swine Fever Vaccine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 WINSUN
6.1.1 WINSUN Corporation Information
6.1.2 WINSUN Description and Business Overview
6.1.3 WINSUN Swine Fever Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 WINSUN Swine Fever Vaccine Product Portfolio
6.1.5 WINSUN Recent Developments/Updates
6.2 CAHIC
6.2.1 CAHIC Corporation Information
6.2.2 CAHIC Description and Business Overview
6.2.3 CAHIC Swine Fever Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 CAHIC Swine Fever Vaccine Product Portfolio
6.2.5 CAHIC Recent Developments/Updates
6.3 Merial
6.3.1 Merial Corporation Information
6.3.2 Merial Description and Business Overview
6.3.3 Merial Swine Fever Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Merial Swine Fever Vaccine Product Portfolio
6.3.5 Merial Recent Developments/Updates
6.4 MSD Animal Health
6.4.1 MSD Animal Health Corporation Information
6.4.2 MSD Animal Health Description and Business Overview
6.4.3 MSD Animal Health Swine Fever Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 MSD Animal Health Swine Fever Vaccine Product Portfolio
6.4.5 MSD Animal Health Recent Developments/Updates
6.5 Chopper Biology
6.5.1 Chopper Biology Corporation Information
6.5.2 Chopper Biology Description and Business Overview
6.5.3 Chopper Biology Swine Fever Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Chopper Biology Swine Fever Vaccine Product Portfolio
6.5.5 Chopper Biology Recent Developments/Updates
6.6 Ceva
6.6.1 Ceva Corporation Information
6.6.2 Ceva Description and Business Overview
6.6.3 Ceva Swine Fever Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Ceva Swine Fever Vaccine Product Portfolio
6.6.5 Ceva Recent Developments/Updates
6.7 ChengDu Tecbond
6.6.1 ChengDu Tecbond Corporation Information
6.6.2 ChengDu Tecbond Description and Business Overview
6.6.3 ChengDu Tecbond Swine Fever Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 ChengDu Tecbond Swine Fever Vaccine Product Portfolio
6.7.5 ChengDu Tecbond Recent Developments/Updates
6.8 Veterinary
6.8.1 Veterinary Corporation Information
6.8.2 Veterinary Description and Business Overview
6.8.3 Veterinary Swine Fever Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Veterinary Swine Fever Vaccine Product Portfolio
6.8.5 Veterinary Recent Developments/Updates
6.9 Ringpu Biology
6.9.1 Ringpu Biology Corporation Information
6.9.2 Ringpu Biology Description and Business Overview
6.9.3 Ringpu Biology Swine Fever Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Ringpu Biology Swine Fever Vaccine Product Portfolio
6.9.5 Ringpu Biology Recent Developments/Updates
6.10 Qilu Animal
6.10.1 Qilu Animal Corporation Information
6.10.2 Qilu Animal Description and Business Overview
6.10.3 Qilu Animal Swine Fever Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Qilu Animal Swine Fever Vaccine Product Portfolio
6.10.5 Qilu Animal Recent Developments/Updates
6.11 DHN
6.11.1 DHN Corporation Information
6.11.2 DHN Swine Fever Vaccine Description and Business Overview
6.11.3 DHN Swine Fever Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.11.4 DHN Swine Fever Vaccine Product Portfolio
6.11.5 DHN Recent Developments/Updates
6.12 CAVAC
6.12.1 CAVAC Corporation Information
6.12.2 CAVAC Swine Fever Vaccine Description and Business Overview
6.12.3 CAVAC Swine Fever Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.12.4 CAVAC Swine Fever Vaccine Product Portfolio
6.12.5 CAVAC Recent Developments/Updates
6.13 Komipharm
6.13.1 Komipharm Corporation Information
6.13.2 Komipharm Swine Fever Vaccine Description and Business Overview
6.13.3 Komipharm Swine Fever Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Komipharm Swine Fever Vaccine Product Portfolio
6.13.5 Komipharm Recent Developments/Updates
6.14 Agrovet
6.14.1 Agrovet Corporation Information
6.14.2 Agrovet Swine Fever Vaccine Description and Business Overview
6.14.3 Agrovet Swine Fever Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Agrovet Swine Fever Vaccine Product Portfolio
6.14.5 Agrovet Recent Developments/Updates
6.15 Bioveta
6.15.1 Bioveta Corporation Information
6.15.2 Bioveta Swine Fever Vaccine Description and Business Overview
6.15.3 Bioveta Swine Fever Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Bioveta Swine Fever Vaccine Product Portfolio
6.15.5 Bioveta Recent Developments/Updates
6.16 Jinyu Bio-Technology
6.16.1 Jinyu Bio-Technology Corporation Information
6.16.2 Jinyu Bio-Technology Swine Fever Vaccine Description and Business Overview
6.16.3 Jinyu Bio-Technology Swine Fever Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Jinyu Bio-Technology Swine Fever Vaccine Product Portfolio
6.16.5 Jinyu Bio-Technology Recent Developments/Updates
6.17 Institutul Pasteur
6.17.1 Institutul Pasteur Corporation Information
6.17.2 Institutul Pasteur Swine Fever Vaccine Description and Business Overview
6.17.3 Institutul Pasteur Swine Fever Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Institutul Pasteur Swine Fever Vaccine Product Portfolio
6.17.5 Institutul Pasteur Recent Developments/Updates
6.18 MVP
6.18.1 MVP Corporation Information
6.18.2 MVP Swine Fever Vaccine Description and Business Overview
6.18.3 MVP Swine Fever Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.18.4 MVP Swine Fever Vaccine Product Portfolio
6.18.5 MVP Recent Developments/Updates
6.19 Tecon
6.19.1 Tecon Corporation Information
6.19.2 Tecon Swine Fever Vaccine Description and Business Overview
6.19.3 Tecon Swine Fever Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.19.4 Tecon Swine Fever Vaccine Product Portfolio
6.19.5 Tecon Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Swine Fever Vaccine Industry Chain Analysis
7.2 Swine Fever Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Swine Fever Vaccine Production Mode & Process
7.4 Swine Fever Vaccine Sales and Marketing
7.4.1 Swine Fever Vaccine Sales Channels
7.4.2 Swine Fever Vaccine Distributors
7.5 Swine Fever Vaccine Customers
8 Swine Fever Vaccine Market Dynamics
8.1 Swine Fever Vaccine Industry Trends
8.2 Swine Fever Vaccine Market Drivers
8.3 Swine Fever Vaccine Market Challenges
8.4 Swine Fever Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
